In this episode of Obesity: A Disease, Dr. Suzanne Cuda, Executive Editor of the Obesity Medicine Association’s Obesity Pillars online journal, interviews Dr. Sarah Ro and Dr. Sushma Chamarthi about their co-authored article, The Impact of Ultra-Processed Foods on Pediatric Health, published in Obesity Pillars. Together they discuss the impact and increasing prevalence of ultra-processed foods into pediatric diets.

Episode Guests:

Sarah Ro, MD, DABOM

Sushma Chamarthi, MD, FAAP, DABOM

Episode Host:

Suzanne Cuda, MD, FOMA, FAAP

Related Resources:

https://www.sciencedirect.com/science/article/pii/S2667368125000476

In this Industry Insights episode of Obesity: A Disease, host Dr. Christopher Weber welcomes Dr. Kevin Trice, Executive Director in the Global Medical Affairs Division of Cardiometabolic Health at Eli Lilly. Dr. Trice will be speaking today on behalf of Lilly. This material is developed under the direction and sponsorship of Lilly Medical Affairs and is intended for US healthcare professional only. Dr. Trice is an employee of Eli Lilly. 

Dr. Kevin Trice joins Dr. Christopher Weber for a focused discussion on the key findings from the SURMOUNT-OSA trial and their implications for clinical practice. Together, they explore how this landmark study informs the evolving management of obesity and obstructive sleep apnea.  This episode is sponsored by Lilly.

Episode Guest: Kevin Trice, MD, MBA

Episode Host: Christopher Weber, MD, FAAP, FACP, CSCS, DABOM, FOMA

Note From the Sponsor

*When discussing tirzepatide for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity, it’s important to emphasize that its safety profile mirrors what we’ve seen in obesity and diabetes indications. The most frequent adverse events are gastrointestinal—nausea, diarrhea, vomiting, and constipation—typically emerging during dose escalation and generally mild to moderate in severity. While these symptoms often resolve over time, clinicians should monitor for persistence or intolerance, as discontinuation, though uncommon, can occur. Serious but rare risks include pancreatitis and gallbladder disease; patients presenting with severe abdominal pain warrant immediate evaluation.

Tirzepatide carries a boxed warning for thyroid C-cell tumors based on rodent data, with uncertain relevance to humans. It is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2. Physicians should counsel patients on recognizing symptoms such as neck swelling or persistent hoarseness. Additional precautions include vigilance for severe gastrointestinal symptoms, hypersensitivity reactions, and pancreatitis. Use during pregnancy is not recommended, and effective contraception should be discussed. Finally, consider potential drug interactions and reinforce lifestyle interventions to optimize outcomes alongside pharmacotherapy.*

In this eighth and final episode of the series, Dr. Allison Rhodes concludes the discussion on obesity and orthopedic health with Dr. Cherise Dyal, focusing on the unique post-operative risks and recovery challenges following lower extremity surgery in patients with obesity. Together, they examine complications in lower extremity procedures that can be influenced by obesity, as well as the factors contributing to extended recovery timelines and complex rehabilitation needs.

The episode also explores strategies to enhance surgical and functional outcomes.  Dr. Rhodes and Dr. Dyal underscore the importance of a team-based, patient-centered approach that supports safe recovery, sustained mobility, and long-term musculoskeletal health.

This podcast offers 0.25 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy. 

*This activity is supported by an independent educational grant from Novo Nordisk Inc.

Episode Guest: Dr. Cherise Dyal, MD, DABOM is a Board Certified Orthopedic Surgeon. She is a Fellow of the American Academy of Orthopedic Surgery and is also Board Certified in Obesity Medicine.

Episode Host: Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center

In this seventh episode of our eight part series, Dr. Allison Rhodes welcomes Dr. Cherise Dyal, MD, DABOM. Dr. Dyal is a Board Certified Orthopedic Surgeon and together, they examine the complex relationship between obesity and lower extremity disorders. The discussion explores the heightened prevalence of foot, ankle, hip, and knee conditions among individuals with obesity and how these issues contribute to pain, reduced mobility, and diminished quality of life.

Dr. Dyal provides a clinical perspective on the management of common lower extremity conditions in patients with obesity, as well as strategies to optimize patient outcomes. The episode highlights evidence-based approaches that support mobility, mitigate progression, and enhance overall musculoskeletal health.

This podcast offers 0.25 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy. 

*This activity is supported by an independent educational grant from Novo Nordisk Inc.

Episode Guest: Dr. Cherise Dyal, MD, DABOM is a Board Certified Orthopedic Surgeon. She is a Fellow of the American Academy of Orthopedic Surgery and is also Board Certified in Obesity Medicine.

Episode Host: Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center

In this sixth episode of our eight part series, Dr. Allison Rhodes welcomes back Dr. Megha Poddar, MD, FRCPC, DABOM, to explore the unique challenges of managing endocrine disorders in patients with obesity. They discuss the complexities of medication dosing and efficacy, diagnostic limitations, and barriers to lifestyle change, along with the long-term management of diabetes, PCOS, and thyroid disease and their impact on metabolic and reproductive health.

The conversation also highlights exciting advances in endocrine care, updates in fertility and PCOS management, and the integration of metabolic surgery into treatment plans. Together, Dr. Rhodes and Dr. Poddar emphasize the importance of a compassionate, patient-centered approach that addresses the interconnected nature of hormone and metabolic health to support better long-term outcomes.

This podcast offers 0.5 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy. 

*This activity is supported by an independent educational grant from Novo Nordisk Inc.

Episode Guest:

Megha Poddar, MD, FRCPC, DABOM is an endocrinologist and obesity medicine specialist, Medical Director of the Medical Weight Management Centre of Canada, and Assistant Clinical Professor at McMaster University

Host:

Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center

In this fifth episode of our eight part series, Dr. Allison Rhodes is joined by Dr. Megha Poddar, MD, FRCPC, DABOM, to explore how obesity intersects with hormone health. Together, they examine the complex relationship between obesity and endocrine function, highlighting how hormonal imbalances influence metabolic and reproductive health.

Dr. Poddar discusses key conditions linked to obesity, including insulin resistance and Type 2 diabetes, MASLD/MASH, metabolic syndrome, thyroid disorders, and polycystic ovary syndrome (PCOS). The conversation also emphasizes the importance of early screening, lifestyle interventions, and collaboration between endocrinology and obesity medicine to improve patient outcomes.

This podcast offers 0.5 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy. 

*This activity is supported by an independent educational grant from Novo Nordisk Inc.

Episode Guest:

Megha Poddar, MD, FRCPC, DABOM is an endocrinologist and obesity medicine specialist, Medical Director of the Medical Weight Management Centre of Canada, and Assistant Clinical Professor at McMaster University

Host:

Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center

Hosted by Dr. Allison Rhodes, this exciting new 8 part series explores how obesity intersects with a wide range of medical specialties. In each episode, we’ll dive into the challenges and opportunities for improving patient care when addressing obesity in different clinical contexts.

In this fourth episode, Dr. Allison Rhodes is joined again by Dr. Kimberley Sampson-Paine to explore the unique challenges and advances in gynecological care for patients with obesity. Building on the foundation of Episode 3, they shift the focus to clinical management and treatment advances.

This podcast offers 0.25 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy. 

*This activity is supported by an independent educational grant from Novo Nordisk Inc.

Episode Guest:

Kimberley Sampson-Paine, MD, MSc, FACOG, DABOM, DACLM, MSCP, FOMA, Chair of Obstetrics and Gynecology at Southwestern Vermont Medical Center, Assistant Professor at the Geisel School of Medicine at Dartmouth, and Vice President of the New England Obesity Society

Host:

Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center

Hosted by Dr. Allison Rhodes, this exciting new 8 part series explores how obesity intersects with a wide range of medical specialties. In each episode, we’ll dive into the challenges and opportunities for improving patient care when addressing obesity in different clinical contexts.

In this third episode, Dr. Allison Rhodes is joined by Dr. Kimberley Sampson-Paine to explore how obesity impacts women’s reproductive health. They discuss key gynecological conditions, including menstrual irregularities, infertility, PCOS, pregnancy complications, and increased cancer risk and highlight the importance of early screening, prevention strategies, and patient-centered care to improve outcomes.

This episode offers 0.25 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy. 

*This activity is supported by an independent educational grant from Novo Nordisk Inc.

Episode Guest:

Kimberley Sampson-Paine, MD, MSc, FACOG, DABOM, DACLM, MSCP, FOMA, Chair of Obstetrics and Gynecology at Southwestern Vermont Medical Center, Assistant Professor at the Geisel School of Medicine at Dartmouth, and Vice President of the New England Obesity Society

Host:

Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center

Hosted by Dr. Allison Rhodes, this exciting new 8-part series explores how obesity intersects with a wide range of medical specialties. In each episode, we’ll dive into the challenges and opportunities for improving patient care when addressing obesity in different clinical contexts.

In this second episode, we return to the world of cardiac care with Dr. Alison Bailey. Dr. Rhodes and Dr. Bailey discuss cardiac complications associated with obesity and explore the latest advances in treatment and patient management. Together, they highlight how emerging approaches and cross-specialty collaboration are shaping better outcomes for patients at risk of or living with heart disease.

This podcast offers 0.25 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy. 

*This activity is supported by an independent educational grant from Novo Nordisk Inc.

Episode Guest: Alison Bailey, MD, FAACVPR, FACC, FASPC, chief of Cardiology for Centennial Heart at Parkridge in Chattanooga, Tennessee and a Physician Director of Cardiovascular Disease for HCA Healthcare

Host: Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center

Hosted by Dr. Allison Rhodes, this exciting new 8 part series explores how obesity intersects with a wide range of medical specialties. In each episode, we’ll dive into the challenges and opportunities for improving patient care when addressing obesity in different clinical contexts.

In our premiere episode, we turn our focus to cardiac care with Dr. Alison Bailey, a leading voice in cardiovascular medicine. Together, Dr. Rhodes and Dr. Bailey unpack how obesity impacts heart health, the unique challenges cardiologists face in treating patients with obesity, and the opportunities for collaboration across specialties to improve outcomes.

This podcast offers 0.25 AMA PRA Category 1 Credits™. To claim credit please visit the OMA Academy. 

*This activity is supported by an independent educational grant from Novo Nordisk Inc.

Episode Guest:

Alison Bailey, MD, FAACVPR, FACC, FASPC, Chief of Cardiology for Centennial Heart at Parkridge in Chattanooga, Tennessee and a Physician Director of Cardiovascular Disease for HCA Healthcare

Host:

Allison Rhodes, MD, FOMA, Obesity Medicine Physician with the Comprehensive Weight Management Program at The Ohio State University Wexner Medical Center